Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. who-umc.org › about-uppsala-monitoring-centre › ourOur organisation | UMC

    22 de feb. de 2024 · About Uppsala Monitoring Centre Our organisation. How we’re organised. Under the supervision of the UMC board, the Director works closely with the Executive Management Team (EMT) to lead the organisation in all its operations. Last modified on: June 24, 2024. Follow us on social media:

  2. Hace 1 día · Around the world / 26 June 2024. To raise awareness of phytovigilance in healthcare, ISoP Egypt created an outreach proposal centred on sharing information, experiences, and anecdotes of the safety of herbals. Pharmacovigilance in Egypt is evolving, but some aspects of its scope remain underdeveloped and require further outreach.

  3. Hace 4 días · The Egyptian Drug Authority (EDA) has created an online platform, in cooperation with Sweden-based Uppsala Monitoring Centre (UMC), for healthcare providers to report pharmaceutical products that are ineffectual or have adverse side effects.

  4. Hace 2 días · SBG was funded by the Carnegie Corporation of New York (Grant No. G-19-57145), Sida (Grant No. 54100113), Uppsala Monitoring Center, Norwegian Agency for Development Cooperation (Norad) and by the Wellcome Trust [reference no. 107768/Z/15/Z] and the UK Foreign, Commonwealth & Development Office, with support from the Developing Excellence in Leadership, Training and Science in Africa (DELTAS ...

  5. Hace 4 días · The ministry is directly linked to the WHO’s Uppsala Monitoring Centre (UMC) and is constantly monitoring websites that market medicines. The UAE is doing its best to shoulder its responsibility and play its full role in combating falsified drugs”. WHO Efforts.

  6. Hace 2 días · EudraVigilance Data Warehouse (pharmacovigilance database) and Analysis System (EVDAS), to support the EU pharmacovigilance safety monitoring activities with the main focus on signal detection and evaluation of ICSRs.

  7. Hace 4 días · Male sex (OR 19.540, 95% CI 2.440–156.647) and cancer di-agnosis (OR 18.115, 95% CI 3.246–101.101) are the major clinical predictors for increased risk of hospitalizations due to serious drug-induced cognitive impairment.